Dog Bites

Dog Bites: A Comprehensive Academic Overview of Aetiology, Management, and Preventive Strategies

A dog bite, defined as a penetration or abrasion of the skin resulting from canine dentition, constitutes a significant public health concern globally. Despite their ubiquity as companion animals, dogs are responsible for millions of bite-related injuries annually, often necessitating clinical intervention. Pediatric populations are particularly vulnerable due to their behavioural tendencies and smaller physical stature.

Beyond acute trauma, dog bites pose serious risks due to their potential to transmit pathogenic organisms. Rabies, an invariably fatal viral encephalitis, is of principal concern in endemic regions. Additional complications include bacterial infections such as cellulitis, tetanus, and in some cases, psychological sequelae such as post-traumatic stress disorder (PTSD). The interdisciplinary approach to managing dog bites must include immediate wound care, infection prophylaxis, and legal reporting protocols.

Image source Google

Common Aetiologies of Canine Aggression

Dog bites are multifactorial events, often precipitated by environmental and behavioural stimuli. Core motivators include:

Fear-Induced Aggression: Provoked by sudden threats or perceived danger, dogs may bite defensively when startled.
Pain or Pathology: Dogs experiencing somatic distress may display increased irritability and reduced tolerance to handling.
Territoriality: Defensive behaviour may be evoked when a dog perceives encroachment upon its designated space or possessions.
Insufficient Socialisation: A lack of exposure to diverse stimuli during critical developmental periods can lead to unpredictability in unfamiliar contexts.
Provocative Interaction: Unintended rough play, particularly from children, may be misinterpreted as aggression by the dog.

Breed-specific tendencies, while a topic of contention, may influence aggression thresholds. However, behavioural cues such as growling, stiffening posture, or retreat should be interpreted with clinical vigilance to pre-empt escalation.

Image source Google

You should also know about : Metoclopramide

WHO Classification of Dog Bites

The World Health Organization delineates bite exposures into three distinct categories to guide clinical response:

Category I: Non-contact interactions, including touching or feeding without skin compromise.
- Clinical Implication: No prophylaxis indicated.
Category II: Minor abrasions or superficial scratches without active bleeding.
- Clinical Implication: Rabies vaccination is warranted.
Category III: Deep punctures, bleeding wounds, or exposure to mucosal membranes (e.g., eyes, mouth).
- Clinical Implication: Rabies vaccination and administration of human rabies immunoglobulin (HRIG) are imperative.

This stratification aids in triaging patients and allocating resources appropriately, especially in resource-limited settings.

Immediate First Aid Protocol

Early wound management is pivotal in reducing microbial colonisation and subsequent infection. Recommended protocol includes:

Mechanical irrigation with soap and copious water for a minimum of 15 minutes.
Chemical disinfection using agents such as povidone-iodine or isopropyl alcohol.
Haemostasis via sterile compression to control bleeding.
Sterile occlusion of the wound with gauze or dressing.
Avoidance of non-evidence-based remedies (e.g., herbal pastes).
Deferred suturing in high-risk cases unless clinically justified.

These interventions provide foundational control before professional evaluation and prophylaxis.

Clinical Indications for Medical Consultation

Professional medical intervention is essential in the following scenarios:

Category III exposure or visibly deep lacerations.
Bites in cosmetically or functionally sensitive areas (e.g., face, hands, genitals).
Unknown or unverified rabies immunisation status of the offending animal.
Clinical signs of infection: erythema, oedema, purulence, or systemic febrile response.
Immunocompromised patients or high-risk cohorts (e.g., children, elderly).
Uncertain tetanus immunisation history.

Prompt intervention mitigates risks of systemic involvement and long-term morbidity.

Pathogenic Risks: Rabies and Secondary Infections

Rabies, transmitted via infected saliva, remains a virological emergency with a nearly 100% case fatality rate post-onset. However, its prevention through timely PEP is highly effective.

Other notable pathogens include:

Clostridium tetani – causes tetanus; vaccination status must be verified.
Streptococcus spp., Staphylococcus aureus, Pasteurella multocida, Capnocytophaga canimorsus – implicated in soft tissue and systemic infections.

Immunocompromised individuals warrant heightened surveillance and broader antimicrobial coverage.

Evidence-Based Medical Management

The post-bite clinical approach integrates both prophylactic and therapeutic strategies:

Rabies Vaccination (PEP - Intramuscular): Administered intramuscularly on Days 0, 3, 7, 14, and 28. A Day 90 booster may be indicated.
- Sites for Intramuscular Administration: Deltoid muscle (preferred for adults and older children), or anterolateral thigh (recommended for infants and young children). The gluteal region is avoided due to the risk of suboptimal absorption.
Intradermal Rabies Prophylaxis: Recommended in settings where cost-effective vaccination is prioritized. Vaccines are administered intradermally at two sites per session:
- Sites: Deltoid region or lateral thigh.
- Doses: 0.1 mL per site.
- Schedule: 2-site injections on Days 0, 3, 7, and 28 (updated Thai Red Cross schedule).
HRIG (Human Rabies Immunoglobulin):
- Categories: Indicated exclusively for Category III exposures.
- Types: Equine Rabies Immunoglobulin (ERIG) and Human Rabies Immunoglobulin (HRIG).
- Dose: HRIG is given at 20 IU/kg body weight; ERIG at 40 IU/kg.
- Sites of Administration: As much as possible is infiltrated directly around and into the wound(s). Remaining volume is administered intramuscularly at a site distant from the rabies vaccine (e.g., gluteus or thigh).
- Frequency: Single administration only, ideally within the first 24 hours of exposure and no later than 7 days after the first rabies vaccine dose.
Tetanus Prophylaxis: Indicated if no booster has been received within the preceding 5–10 years.
Antibiotic Therapy: Broad-spectrum coverage, typically with amoxicillin-clavulanate, tailored as per microbial culture if needed.
Surgical Debridement: Indicated for necrotic tissue or extensive contamination.

Monitoring includes reassessment for infection and ensuring adherence to the vaccine schedule.

Legal and Public Health Obligations

Post-bite legal and safety steps include:

Reporting to authorities (animal control, public health departments).
Owner identification and verification of canine vaccination history.
Incident documentation via photographs, written accounts, and clinical records.
Medical certification detailing the nature and extent of injury.
Police notification if criminal negligence is suspected.
Legal consultation for liability or compensation claims.

Compliance ensures both public safety and individual legal protection.

Preventive Strategies

Mitigating dog bite risks involves behavioural, environmental, and educational approaches:

Avoid initiating contact with unfamiliar or unsupervised dogs.
Never disturb a dog that is feeding, sleeping, or tending offspring.
Educate children on canine behaviour and appropriate interaction.
Ensure routine veterinary care and vaccination of domestic pets.
Employ leashing and muzzling protocols in public spaces where mandated.
Incorporate canine behavioural training and desensitisation programs.

Preventive education remains the most effective long-term intervention.

Myth vs. Evidence-Based Understanding

Myth: Small dogs pose negligible risk.
- Evidence: Bite severity is not proportionally correlated with dog size.
Myth: Only stray dogs carry rabies.
- Evidence: Any non-vaccinated dog, regardless of ownership, can be a vector.
Myth: Absence of bleeding indicates minimal risk.
- Evidence: Non-bleeding wounds may still introduce pathogens.
Myth: All dogs signal before attacking.
- Evidence: Not all bites are preceded by audible or visible cues.

Dispelling misinformation is essential to improving preventive behaviours.

Veterinary and Medical Follow-Up

Human Medical Follow-Up:

All Category II and III exposures.
Signs of systemic or local infection.
Unknown rabies or tetanus status of the dog.

Veterinary Protocol:

Immediate evaluation following any biting incident.
Verification and updating of rabies vaccination.
Observation for signs of disease or abnormal aggression.
Compliance with local public health reporting requirements (e.g., 10-day quarantine).

Conclusion

Dog bites present a multifaceted health issue that intersects with clinical medicine, public health, and animal behaviour science. While inherently preventable, they continue to exact a significant human and societal toll. Rabies alone is responsible for an estimated 59,000 global deaths annually, primarily in underserved regions lacking access to timely prophylaxis.

Adhering to best practices in wound care, recognising risk factors, and understanding the medical and legal framework surrounding dog bites empowers clinicians, public health officials, and the general population to minimise incidence and improve outcomes. Academic engagement in canine-human interaction research is imperative to shaping evidence-based prevention strategies.

Ultimately, fostering responsible pet ownership and public education will remain central to reducing the burden of dog bite injuries and associated complications.

References

World Health Organization. Rabies vaccines: WHO position paper. Weekly Epidemiological Record. 2018;93(16):201–220.
Centers for Disease Control and Prevention (CDC). Rabies. https://www.cdc.gov/rabies/
Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet. 2004;363(9413):959–969.
Sudarshan MK, et al. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. International Journal of Infectious Diseases. 2007;11(1):29–35.
Bharti OK. Intradermal rabies vaccination: an update. Human Vaccines & Immunotherapeutics. 2016;12(3):566–570.